Penumbra PEN
NYSE PEN
$319.80 +0.54 (+0.17%)
As of: Sep 9, 2026 · 12:53 PM EDT

Penumbra (PEN) Income from Continuing Operations (2014 - 2026)

Penumbra's (PEN) quarterly Income from Continuing Operations came in at $34.8 million in Q2 2026, down 23.16% year-over-year from $45.3 million in Q2 2025, and up 6.76% quarter-over-quarter from $32.6 million in Q1 2026.

Analysis

Penumbra (PEN) Income from Continuing Operations (2014 - 2026) Analysis & Trends

Penumbra (PEN) has reported Income from Continuing Operations for 13 consecutive years, with $34.8 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Income from Continuing Operations fell 23.16% year-over-year to $34.8 million in Q2 2026; TTM through Jun 2026 was $160.5 million, a 8.73% increase from a year earlier, with the FY2025 full-year figure at $177.7 million, up 1168.11% from the prior year.
  • Income from Continuing Operations was $34.8 million for Q2 2026 at Penumbra, up from $32.6 million in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at $54.2 million in Q4 2023 and troughed at -$60.2 million in Q2 2024.
  • A 5-year average of $19.3 million and a median of $24.2 million in 2023 frame the typical range for Income from Continuing Operations.
  • Across the five-year window, Income from Continuing Operations soared 10725.32% in 2023 and slumped 417.78% in 2024, its largest moves.
  • Over 5 years, Income from Continuing Operations stood at $3.9 million in 2022, then jumped by 1298.45% to $54.2 million in 2023, then plunged by 37.88% to $33.7 million in 2024, then surged by 40.56% to $47.3 million in 2025, then decreased by 26.52% to $34.8 million in 2026.
  • The last three Income from Continuing Operations figures came in at $34.8 million (Q2 2026), $32.6 million (Q1 2026), and $47.3 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 183.86 Bn 178.25 Bn 7.27 Bn 928.00 Mn
2 Intuitive Surgical 124.18 Bn 118.97 Bn 1.96 Bn 823.20 Mn
3 Medtronic 118.18 Bn 109.36 Bn 6.34 Bn 1.48 Bn
4 Stryker 104.54 Bn 101.07 Bn 4.50 Bn 1.28 Bn
5 Boston Scientific 66.34 Bn 65.80 Bn 3.85 Bn 905.00 Mn
6 Edwards Lifesciences 49.64 Bn 45.39 Bn 1.35 Bn 241.40 Mn
7 Alcon 33.93 Bn 32.47 Bn 1.68 Bn -92.00 Mn
8 Dexcom 32.20 Bn 30.25 Bn 830.00 Mn 249.10 Mn
9 Steris 21.14 Bn 20.66 Bn 684.20 Mn 201.00 Mn
10 Penumbra 12.58 Bn 11.92 Bn 264.94 Mn 34.79 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 34.79 Mn
Mar 31, 2026 32.58 Mn
Dec 31, 2025 47.34 Mn
Sep 30, 2025 45.83 Mn
Jun 30, 2025 45.27 Mn
Mar 31, 2025 39.22 Mn
Dec 31, 2024 33.68 Mn
Sep 30, 2024 29.48 Mn
Jun 30, 2024 -60.17 Mn
Mar 31, 2024 11.00 Mn
Dec 31, 2023 54.22 Mn
Sep 30, 2023 9.20 Mn
Jun 30, 2023 18.94 Mn
Mar 31, 2023 8.55 Mn
Dec 31, 2022 3.88 Mn
Sep 30, 2022 -2.27 Mn
Jun 30, 2022 -3.69 Mn
Mar 31, 2022 79,000.00
Dec 31, 2021 -24.63 Mn
Sep 30, 2021 8.03 Mn